1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    Person holding a blue chip.
    Opinions

    Buy alert! 2 ASX 200 blue-chip shares worth a look now: expert

    | Bronwyn Allen

    Dylan Evans from Catapult Wealth has identified two blue-chip shares that he thinks are good buys today.

    Read more »

    A group of people in a corporate setting do a collective high five.
    Healthcare Shares

    Should I buy Pro Medicus or CSL shares ahead of earnings season?

    | Laura Stewart

    The ASX healthcare sector may be currently undervalued.

    Read more »

    A couple sit in front of a laptop reading ASX shares news articles and learning about ASX 200 bargain buys
    Share Market News

    Are blue-chip stocks or ASX ETFs a better investment?

    | Aaron Bell

    Lets compare these two investment options based on long term returns. 

    Read more »

    A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
    Broker Notes

    Top brokers name 3 ASX shares to buy next week

    | James Mickleboro

    Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

    Read more »

    Three happy office workers cheer as they read about good financial news on a laptop.
    How to invest

    The 3 rules new ASX share investors should always follow

    | James Mickleboro

    These rules could help you generate wealth in the share market.

    Read more »

    Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
    Broker Notes

    Brokers name 3 ASX shares to buy today

    | James Mickleboro

    Here's why brokers are feeling bullish about these three shares this week.

    Read more »

    couple having a happy discussion with a banker
    Healthcare Shares

    Expert: 4 ASX healthcare stocks to buy ahead of reporting season

    | Laura Stewart

    Could these ASX healthcare stocks be good additions to your portfolio?

    Read more »

    A man holding a cup of coffee puts his thumb up and smiles while at laptop.
    Broker Notes

    Morgans names 3 ASX stocks to buy

    | James Mickleboro

    The broker is feeling very positive on the investment opportunities here.

    Read more »

    A woman sits at a table with notebook on lap and pen in hand as she gazes off to the side with the pen resting on the side of her face as though she is thinking and contemplating while a glass of orange juice and a pair of red sunglasses rests on the table beside her.
    Share Market News

    Will these ASX 100 shares surge or sink in July?

    | Aaron Bell

    These are two ASX favourites to watch closely this month. 

    Read more »

    A couple stares at the tv in shock, with the man holding the remote up ready to press a button.
    Broker Notes

    These ASX 200 shares could rise 20% to 35%

    | James Mickleboro

    Let's see why these shares are being tipped to rise strongly from where they trade.

    Read more »

    Smiling couple looking at a phone at a bargain opportunity.
    Cheap Shares

    2 cheap ASX 200 shares that look too good to ignore today

    | Sebastian Bowen

    Cheap shares are hard, but not impossible, to find right now.

    Read more »

    A smiling woman sits in a cafe reading a story on her phone about Rio Tinto and drinking a coffee with a laptop open in front of her.
    How to invest

    How to start your ASX share portfolio with just $1,000

    | James Mickleboro

    Investing doesn't need to be hard. Here's an easy way to start.

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note